tert-butyl (+/-)-6-[(trans-1'-benzyl-4'-hydroxypyrrolidin-3'-yl)methyl]pyridin-2-ylcarbamate

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: tert-butyl (+/-)-6-[(trans-1'-benzyl-4'-hydroxypyrrolidin-3'-yl)methyl]pyridin-2-ylcarbamate
• 英文别名: trans-[6-(1-benzyl-4-hydroxy-pyrrolidin-3-ylmethyl)-pyridin-2-yl]-carbamic acid tert-butyl ester；[6-(1-benzyl-4-hydroxy-pyrrolidin-3-ylmethyl)-pyridin-2-yl]-carbamic acid tert-butyl ester；tert-butyl N-[6-[[(3R,4S)-1-benzyl-4-hydroxypyrrolidin-3-yl]methyl]pyridin-2-yl]carbamate
• 化学式: C₂₂H₂₉N₃O₃
• 分子量: 383.491
• InChiKey: GPOMYIAVNNBSLG-IEBWSBKVSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3
• 重原子数：
  28
• 可旋转键数：
  7
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.45
• 拓扑面积：
  74.7
• 氢给体数：
  2
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  tert-butyl (+/-)-6-[(trans-1'-benzyl-4'-hydroxypyrrolidin-3'-yl)methyl]pyridin-2-ylcarbamate 在 草酰氯 、 二甲基亚砜 、 三乙胺 作用下， 以 二氯甲烷 为溶剂， 反应 2.0h， 以87%的产率得到tert-butyl (+/-)-6-[(1'-benzyl-4'-oxopyrrolidin-3'-yl)methyl]pyridin-2-ylcarbamate
  参考文献：
  名称：

  WO2008/42353

  摘要：

  公开号：
• 作为产物：
  描述：

  3-苄基-6-氧杂-3-氮杂双环[3.1.0]己烷 在 正丁基锂 作用下， 以 四氢呋喃 、 hexanes 为溶剂， 反应 6.0h， 以90%的产率得到tert-butyl (+/-)-6-[(trans-1'-benzyl-4'-hydroxypyrrolidin-3'-yl)methyl]pyridin-2-ylcarbamate
  参考文献：
  名称：

  [EN] HETEROAROMATIC SELECTIVE INHIBITORS OF NEURONAL NITRIC OXIDE SYNTHASE
  [FR] INHIBITEURS HETEROMATIQUES SELECTIFS D'OXYDE NITRIQUE SYNTHASE NEURONALE

  摘要：

  公开号：

  WO2005026111A3

文献信息

• Potent and highly selective heteroaromatic inhibitors of neuronal nitric oxide synthase
  申请人：Silverman B. Richard

  公开号：US20080108814A1

  公开（公告）日：2008-05-08

  Peptidomimetic compounds as can inhibit neuronal nitric oxide synthase (nNOS) for potential treatment in neurodegenerative diseases, such as but not limited to stroke, Alzheimer's disease, Parkinson's disease, Huntington's disease.

  肽类类似物化合物可抑制神经元一氧化氮合酶(nNOS)，用于潜在的治疗神经退行性疾病，如中风、阿尔茨海默病、帕金森病、亨廷顿病等。
• Heteroaromatic Selective Inhibitors of Neuronal Nitric Oxide Synthase
  申请人：Silverman Richard B.

  公开号：US20090104677A1

  公开（公告）日：2009-04-23

  Compounds inhibiting neuronal nitric oxide synthase (nNOS) for potential treatment in neurodegenerative diseases, such as stroke, Alzheimer's disease, Parkinson's disease, Huntington's disease, such compounds of a formula.

  抑制神经元一氧化氮合酶(nNOS)的化合物，用于潜在治疗神经退行性疾病，如中风、阿尔茨海默病、帕金森病、亨廷顿病等，这些化合物的公式为：
• WO2008/42353
  申请人：——

  公开号：——

  公开（公告）日：——
• Exploration of the Active Site of Neuronal Nitric Oxide Synthase by the Design and Synthesis of Pyrrolidinomethyl 2-Aminopyridine Derivatives
  作者：Haitao Ji、Silvia L. Delker、Huiying Li、Pavel Martásek、Linda J. Roman、Thomas L. Poulos、Richard B. Silverman

  DOI：10.1021/jm100947x

  日期：2010.11.11

  Neuronal nitric oxide synthase (nNOS) represents an important therapeutic target for the prevention of brain injury and the treatment of various neurodegenerative disorders. A series of trans-substituted amino pyrrolidinomethyl 2-aminopyridine derivatives (8-34) was designed and synthesized. A structure activity relationship analysis led to the discovery of low nanomolar nNOS inhibitors ((+/-)-32 and (+/-)-34) with more than 1000-fold selectivity for nNOS over eNOS. Four enantiomerically pure isomers of 3'-[2 ''-(3 ''-fluorophenethylamino)ethoxy]pyrrolidin-4'-yl}methyl}-4-methylpyridin-2-amine (4) also were synthesized. It was found that (3'R,4'R)-4 can induce enzyme elasticity to generate a new "hot spot" for ligand binding. The inhibitor adopts a unique binding mode, the same as that observed for (3'R,4'R)-3'-[2 ''-(3'''-fluorophenethylamino)ethylamino]pyrrolidin-4'-yl}methyl}-4-methylpyridin-2-amine ((3'R,4'R)-3) (J. Am. Chem. Soc. 2010, 132 (15), 5437-5442). On the basis of structure-activity relationships of 8-34 and different binding conformations of the cis and trans isomers of 3 and 4, critical structural requirements of the NOS active site for ligand binding are revealed.
• US7470790B2
  申请人：——

  公开号：US7470790B2

  公开（公告）日：2008-12-30